Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quibim
Valencia, Valencia, Spainquibim.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Quibim has developed over two dozen AI algorithms for quantitative analysis of medical images. Their solutions are used by more than seventy hospitals worldwide and support at least eleven clinical trials. The company’s products have received regulatory clearances such as FDA approval for their prostate cancer detection tool. They have demonstrated value in improving diagnostic accuracy and efficiency across oncology and neurology indications.
- Therapeutic areas
- OncologyRheumatologyGastroenterologyNeurologyInfectious Diseases
- Modalities
- Artificial intelligence algorithms for medical imaging (radiomics and deep learning)Not directly therapeutic; focuses on diagnostics and biomarkers from MRI, CT, PET scans
- Industry
- Medical Imaging
02
Partnerships
Beyond the preview
Go deeper on Quibim.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quibim.